Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Dáil Éireann díospóireacht -
Wednesday, 17 Apr 1996

Vol. 464 No. 1

Adjournment Debate. - Asthma Sufferers' Benefits.

I thank the Ceann Comhairle for selecting my matter on the Adjournment. I am also grateful to the Minister of State for attending to reply to the debate.

I wish to draw the Minister's attention to the fact that, in recent weeks, hundreds of drug costs subsidisation scheme cardholders have had their cards withdrawn in the Southern Health Board region; this may also have occurred in other health board areas. The result is that severe hardship has been inflicted on cardholders and I ask the Minister to take immediate action to resolve the matter.

The scheme was introduced in 1990 mainly as a result of long and hard lobbying by the Asthma Association of Ireland. The main victims of the move to withdraw the cards are asthma sufferers. As the scheme is currently administered, DCSS holders are required to avail of the scheme in 11 of the preceding 12 months. Those who fail to meet the criteria have had their cards withdrawn. The Minister will agree that this approach goes against the spirit in which the regulation was made in the House in the first instance. He will also agree that it is unrealistic and highly impractical to put this requirement on holders of DCSS cards because asthma suffers can be clear of their condition for a number of consecutive months. When they are clear of their condition, they do not need treatment for that period. That is the nature of their ailment. However, when asthma strikes, these people need their cards because of the high cost of essential medicines. It should be borne in mind that inhalers can be dispensed to an asthma sufferer in January which, depending on the weather and other factors, may not be used until March. When that happens, a month is skipped and the recipient of the inhaler is deemed ineligible for the scheme.

When questioned the health board argued that cardholders can be reimbursed under the assistance towards the cost of prescribed medicines scheme. The net effect of this arrangement is that a cardholder would be required to carry the cost for each quarter and could then apply for reimbursement at the end of the quarter. However, in practice, reimbursement often does not occur until the fourth, fifth or sixth month. That puts a crippling burden on families and, as a result, a number of families suffer severe hardship, many of whom have spoken to me and whom I know well.

We have to confront this issue. As I understand it, only one of two actions can be taken. The Minister can use his office to direct the health board to apply a more reasonable degree of flexibility and understanding in the administration of the scheme. If that cannot be done, the only alternative is to include asthma in the list of classified long-term illnesses. One of those measures must be taken. I appeal to the Minister to ensure action is taken immediately because the present position is critical, will become more critical, and cannot be allowed continue.

Persons who suffer from an ongoing medical condition, such as asthma, can avail of the drug cost subsidisation scheme. This scheme caters for persons who are certified by their medical practitioner as having a long-term medical condition, such as asthma, with a regular and ongoing requirement for prescribed drugs and medicines. Persons who qualify for inclusion in this scheme will not have to pay more than £32 in any month in respect of prescribed medication.

The drugs cost subsidisation scheme is one of a number of schemes in operation which provide assistance towards the cost of prescribed drugs and medicines to persons with ongoing medical conditions. I understand the Southern Health Board has carried out a review of the drug cost subsidisation scheme in its area. That review showed there were a significant number of people who, although holding a drug cost subsidisation scheme card, had ceased to use it, thus indicating they no longer had an ongoing monthly requirement for prescribed medicines in excess of £32 per month. The board wrote to each person concerned nothing this fact and suggesting they should contact the board to discuss their present situation.

I understand the board subsequently wrote again to each person who did not respond to the board's initial letter, indicating that it would be withdrawing their drug cost subsidisation scheme card and suggesting they should avail of the drugs refund scheme. Under the drugs refund scheme, which covers expenditure by the whole family, any expenditure on prescribed medication above £90 in a calendar quarter is refunded by the health board.

I would emphasise that the Southern Health Board did not unilaterally withdraw the drug cost subsidisation scheme card. The board has confirmed that if a person's situation indicates an ongoing monthly requirement for prescribed medicines in excess of £32 per month, the card will not be withdrawn. I would point out that should a person at a future date have an ongoing requirement for prescribed drugs and medicines in excess of £32 per month, the person may apply to the Southern Health Board for a new drug cost subsidisation scheme card.

Where an individual or a family is subjected to a significant level of ongoing expenditure on medical expenses, for example, general practitioner fees or prescribed medicines, due to a long-term medical condition, these expenses may be reckoned in determining eligibility for a medical card. Eligibility for a medical card is solely a matter for the chief executive officer of the relevant health board to decide.

I am satisfied that appropriate and comprehensive support is being provided by the State and the Southern Health Board through the operation of these various drug schemes to those with medical expenses arising from conditions such as asthma.

Barr
Roinn